Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Scientists working at the NIH’s BRAIN Initiative have created new viral vectors that one day could lead to gene therapies for ...

Developed by Sarepta Therapeutics, Elevidys is a one-time, intravenous treatment that uses adeno-associated virus (AAV) ...

Nucula’s new indication is as an add-on therapy for patients with COPD who also have an elevated blood eosinophil count.

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ...

Patients diagnosed with acquired (autoimmune) hemophilia, a serious and rare bleeding disorder, have high rates of hospital ...

Eric C. Hunter, president and CEO of CareOregon, spoke with Managed Healthcare Executive about the state’s innovative ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Health plan sponsors are also expected to see a reduction in the net cost per prescription of GLP-1 medications to treat obesity.

In this final interview of a three-part video series, Jeffrey Casberg, M.S., vice president of clinical pharmacy at IPD ...

GLP-1s are the main reason why pharmacy expenditures have reached double digits in 2025, a continuing trend from 2024, ...

A personalized gene editing therapy was successfully used to treat an infant with CPS1 deficiency, a disease that causes ...